Steve White

Professor; Co-Director of the Center for Epilepsy Drug Discovery (CEDD)

Department of Pharmacy, Pharmacy Faculty, School Faculty

Telephone: (206) 543-3782


Office Location: Health Sciences Building, H-375X 1959 Pacific Street Box 357630 Seattle, WA 98195-7630


  • BSci, Pharmacy,
  • MS, Pharmacology
  • PhD, Pharmacology

Courses Taught:

  • Pharm 301

Research Interests:

  • Early discovery of Anti-seizure drugs
  • Animal seizure and epilepsy models for drug discovery
  • Pharmaco-resistant epilepsy
  • Impact of adherence on seizure control
  • comorbidities of epilepsy
  • Prevention and disease modification of epilepsy
  • Role of the community pharmacist in the chronic management of the patient with epilepsy


H. Steve White, RpH, Ph.D, earned his baccalaureate degree in Pharmacy and a M.S. in Pharmacology at Idaho State University. He earned his Ph.D. in Pharmacology at the University of Utah where he rose through the academic ranks after joining the College of Pharmacy faculty in 1986.

Before joining the University of Washington School of Pharmacy as Chair of the Department of Pharmacy, White was the principal investigator and scientific director of the NIH-sponsored Anticonvulsant Drug Development (ADD) Program, established in 1975 to identify novel anticonvulsant drugs using established animal seizure and epilepsy models.

White’s research is focused on understanding the factors that contribute to the initiation, propagation, and amelioration of seizure activity.

White has been the recipient of significant research funding from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and he and his collaborators have published over 170 original papers pertaining to the mechanism of action and the pharmacology of antiepileptic drugs. In addition to his academic service, he served as Research Director of CURE (Citizen’s United for Research in Epilepsy), the largest non-governmental provider of epilepsy research funding, from November 2011 until October of 2015, where he assisted in the development of strategic programs that advance transformative epilepsy research that may someday lead to a cure or disease modifying therapy for the patient at risk for developing epilepsy. He continues to serve as a Research Advisor to CURE’s team-science initiatives. He has been a co-organizer of two NIH-sponsored workshops on models of refractory epilepsy and epileptogenesis and currently serves on the organizing committee of the biannual Eilat Conferences on Antiepileptic Drug Development. Additionally, White has been actively engaged as a mentor for the next generation of neuroscientists and epilepsy educators and is frequently invited to speak at national and international congresses.

In 2011, White received an Honorary Doctor of Science from The University of Copenhagen Faculty of Pharmaceutical Sciences, Copenhagen, Denmark. In 2014, he was named the 2014 recipient of the Epilepsy Foundation’s Lifetime Accelerator Award, in recognition of his commitment and pioneering contributions to the field of epilepsy and seizures.

White was appointed as the new chair for the Department of Pharmacy in January, 2016.

Selected Publications: